Updated
For as long as most doctors can remember, the female ovary was set to expire one day. Indeed, once a woman went through menopause and her fertile years were over, the organ was considered finished—a spent shell that had done its job. In fact, one of the nation’s leading reproductive biologists, Francesca Duncan of Northwestern…Continue reading Second Act: What Happens to the Ovary After Menopause?
Updated
We’ve all seen a dog asleep on the kitchen floor while its owner cooks dinner. This image is one of the most ordinary scenes in American life. According to research, for dogs, it is also a slow, steady exposure to industrial chemicals that we often don’t think about when it comes to our four-legged family. Our beloved…Continue reading The Canary on the Kitchen Floor
Updated
A new structure is popping up across the United States, and most of us have never heard the name of it. The massive compound is called a frontier AI data center, a term coined as a legal category by the Biden administration in January 2025, and it represents nothing less than an unprecedented computer empire.…Continue reading Public Land, Private AI Empires
By Jefferey Jaxen Imagine for a moment if drug manufacturers can act unethically when record profits are on the line – perhaps not a stretch. What if those unethical practices and manipulative methods were no longer working on the general public? What if an easier option presented itself? What if unethical pharmaceutical companies could magically…Continue reading Are Statin Makers Eyeing the ‘Anti-Vaxxer’ Censorship Model?
Updated
According to a newly released study performed at the independent German Institute for Quality and Efficiency in Health Care, more than half of the new drugs entering the German healthcare system show absolutely no added benefit. Between 2011 and 2017, researchers examined 216 drugs that passed regulatory approval and entered the German market. Most of these assessed drugs were…Continue reading STUDY: No Evidence Of Added Benefit In Most New Drugs
Updated
“I urge physicians to look for symptoms and report suspected cases so that we can accelerate efforts to address this serious illness,” CDC Director Robert Redfield, MD, said in a news release. Attempting to get out front of 2019’s new season of Acute Flaccid Myelitis (AFM) after the CDC’s publicly embarrassing lack of effort in…Continue reading 11 New Cases of AFM Polio-Like Illness, CDC Looking For Answers
Updated
By Jefferey Jaxen Since Bayer’s merger with Monsanto, the company has had three Roundup cancer cases go to trial – and they have lost them all in spectacular fashion. Bayer AG is currently on the hook for $2.4B from jury decisions yet equally damning in the public eye has been the constant deluge of exposed…Continue reading Google Manipulating Search Suggestions to Hide Roundup’s Cancer Connection, Lawsuits
Updated
By Jefferey Jaxen The American Medical Association (AMA) has taken what many view as an aggressive stance in order to remove several sacred and time-honored barriers to pharmaceutical products with known dangers. One would think that this impetus may be coming from only minority voices representing radical views unbecoming of a professional healthcare system. Shockingly,…Continue reading 3 Reasons Not To Trust The American Medical Association on Vaccines
Updated
We are in the age of multiple historic trials exposing corporate wrongdoing. Alongside mainstream headlines of Bayer AG’s billon-dollar Roundup judgement has been other historic legal cases unfolding. In 2017 Oklahoma Attorney General Mike Hunter accused Johnson & Johnson and its subsidiaries of creating a public nuisance for its alleged role in the opioid crisis,…Continue reading Johnson & Johnson: A Household Name To A Public Downfall
Updated